Compare Stocks: TMCI, PRCT, BVS, and STAA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$14.36 -0.1%	$12.81	$6.26 ▼ $15.89	$1.21B	0.65	659,468 shs	669,918 shs
PRCT PROCEPT BioRobotics	$21.37 -2.7%	$20.35	$16.67 ▼ $41.51	$1.26B	0.91	1.12 million shs	861,034 shs
STAA STAAR Surgical	$23.58 +2.0%	$25.17	$15.59 ▼ $35.87	$1.16B	1.21	844,300 shs	798,351 shs
TMCI Treace Medical Concepts	$4.88 +3.8%	$4.44	$1.17 ▼ $7.63	$305.66M	1.4	391,615 shs	275,355 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	-0.07%	+4.13%	+7.00%	+58.85%	+103.98%
PRCT PROCEPT BioRobotics	-2.73%	+3.74%	+16.90%	-23.21%	-43.53%
STAA STAAR Surgical	+2.03%	+5.31%	-2.24%	-21.37%	-13.69%
TMCI Treace Medical Concepts	+3.83%	+6.09%	+2.95%	+39.03%	-32.69%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$14.36 -0.1%	$12.81	$6.26 ▼ $15.89	$1.21B	0.65	659,468 shs	669,918 shs
PRCT PROCEPT BioRobotics	$21.37 -2.7%	$20.35	$16.67 ▼ $41.51	$1.26B	0.91	1.12 million shs	861,034 shs
STAA STAAR Surgical	$23.58 +2.0%	$25.17	$15.59 ▼ $35.87	$1.16B	1.21	844,300 shs	798,351 shs
TMCI Treace Medical Concepts	$4.88 +3.8%	$4.44	$1.17 ▼ $7.63	$305.66M	1.4	391,615 shs	275,355 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	-0.07%	+4.13%	+7.00%	+58.85%	+103.98%
PRCT PROCEPT BioRobotics	-2.73%	+3.74%	+16.90%	-23.21%	-43.53%
STAA STAAR Surgical	+2.03%	+5.31%	-2.24%	-21.37%	-13.69%
TMCI Treace Medical Concepts	+3.83%	+6.09%	+2.95%	+39.03%	-32.69%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BVS Bioventus	2.83	Moderate Buy	$16.80	16.99% Upside
PRCT PROCEPT BioRobotics	2.19	Hold	$25.09	17.41% Upside
STAA STAAR Surgical	2.08	Hold	$28.40	20.44% Upside
TMCI Treace Medical Concepts	1.86	Reduce	$5.17	5.94% Upside

Current Analyst Ratings Breakdown

Latest TMCI, PRCT, BVS, and STAA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/31/2026	TMCI Treace Medical Concepts	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/17/2026	STAA STAAR Surgical	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$28.00
8/17/2026	BVS Bioventus	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $19.00
8/17/2026	BVS Bioventus	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$15.00
8/17/2026	STAA STAAR Surgical	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$31.00 ➝ $28.00
8/14/2026	TMCI Treace Medical Concepts	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/13/2026	STAA STAAR Surgical	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$28.00
8/13/2026	STAA STAAR Surgical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D+)
8/13/2026	STAA STAAR Surgical	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$33.00
8/13/2026	STAA STAAR Surgical	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
8/13/2026	STAA STAAR Surgical	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Sell	$20.00 ➝ $19.00

(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BVS Bioventus	$568.09M	2.13	$1.27 per share	11.27	$3.30 per share	4.35
PRCT PROCEPT BioRobotics	$308.05M	3.97	N/A	N/A	$5.94 per share	3.60
STAA STAAR Surgical	$239.44M	4.94	N/A	N/A	$7.29 per share	3.23
TMCI Treace Medical Concepts	$212.69M	1.49	N/A	N/A	$1.04 per share	4.69

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BVS Bioventus	$22.73M	$0.77	18.65	16.13	1.83	9.36%	28.08%	9.82%	N/A
PRCT PROCEPT BioRobotics	-$95.57M	-$1.94	N/A	N/A	N/A	-32.53%	-30.62%	-22.10%	11/3/2026 (Estimated)
STAA STAAR Surgical	-$80.45M	$0.07	336.91	43.67	N/A	1.13%	9.05%	6.99%	11/4/2026 (Estimated)
TMCI Treace Medical Concepts	-$59M	-$0.93	N/A	N/A	N/A	-28.99%	-71.37%	-30.49%	11/5/2026 (Estimated)

Latest TMCI, PRCT, BVS, and STAA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	STAA STAAR Surgical	$0.2214	$0.39	+$0.1686	$0.39	$90.60 million	$93.54 million
8/7/2026	Q2 2026	TMCI Treace Medical Concepts	-$0.2980	-$0.24	+$0.0580	-$0.24	$44.02 million	$45.38 million
8/5/2026	Q2 2026	BVS Bioventus	$0.22	$0.22	N/A	$0.47	N/A	$153.21 million
8/4/2026	Q2 2026	PRCT PROCEPT BioRobotics	-$0.4619	-$0.47	-$0.0081	-$0.47	$92.77 million	$94.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
STAA STAAR Surgical	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BVS Bioventus	0.83	1.69	1.17
PRCT PROCEPT BioRobotics	0.15	6.55	5.35
STAA STAAR Surgical	N/A	4.66	4.03
TMCI Treace Medical Concepts	0.83	2.90	1.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BVS Bioventus	62.94%
PRCT PROCEPT BioRobotics	89.46%
STAA STAAR Surgical	96.70%
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
BVS Bioventus	33.50%
PRCT PROCEPT BioRobotics	4.00%
STAA STAAR Surgical	39.90%
TMCI Treace Medical Concepts	23.42%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BVS Bioventus	1,200	84.09 million	55.92 million	N/A
PRCT PROCEPT BioRobotics	430	57.27 million	54.98 million	Optionable
STAA STAAR Surgical	1,211	50.14 million	30.14 million	Optionable
TMCI Treace Medical Concepts	250	65.04 million	49.80 million	Optionable

TMCI, PRCT, BVS, and STAA Headlines

Recent News About These Companies

Bank of America Corp DE Has $4.31 Million Stock Holdings in Treace Medical Concepts, Inc. $TMCI

August 29, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 5,000 Shares

August 25, 2026 | insidertrades.com

John Treace Acquires 5,000 Shares of Treace Medical Concepts (NASDAQ:TMCI) Stock

August 24, 2026 | marketbeat.com

Insider Buying: Treace Medical Concepts (NASDAQ:TMCI) CEO Acquires 11,000 Shares

August 24, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 39,944 Shares of Stock

August 24, 2026 | marketbeat.com

Weber Capital Management LLC ADV Takes $2.35 Billion Position in Treace Medical Concepts, Inc. $TMCI

August 24, 2026 | marketbeat.com

Treace Medical Concepts Earnings Call Signals Cautious Rebound

August 18, 2026 | tipranks.com

522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC

August 17, 2026 | marketbeat.com

Treace Medical (TMCI) Q2 2026 Earnings Call Transcript

August 14, 2026 | finance.yahoo.com

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts

August 11, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial

August 10, 2026 | marketbeat.com

Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary

August 8, 2026 | finance.yahoo.com

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

August 7, 2026 | marketbeat.com

Treace Medical Concepts: Q2 Earnings Snapshot

August 7, 2026 | seattlepi.comS

Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Treace Medical Concepts Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2026 | zacks.com

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

August 7, 2026 | globenewswire.com

Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

July 24, 2026 | prnewswire.com

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

July 24, 2026 | globenewswire.com

Why Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 5.42%

July 23, 2026 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI, PRCT, BVS, and STAA Company Descriptions

Bioventus NASDAQ:BVS

$14.36 -0.01 (-0.07%)

As of 09/3/2026 04:00 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

PROCEPT BioRobotics NASDAQ:PRCT

$21.37 -0.60 (-2.73%)

As of 09/3/2026 04:00 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

STAAR Surgical NASDAQ:STAA

$23.58 +0.47 (+2.03%)

As of 09/3/2026 04:00 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Treace Medical Concepts NASDAQ:TMCI

$4.88 +0.18 (+3.83%)

As of 09/3/2026 04:00 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMCI, PRCT, BVS, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMCI, PRCT, BVS, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMCI, PRCT, BVS, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI, PRCT, BVS, and STAA Company Descriptions

Bioventus NASDAQ:BVS

PROCEPT BioRobotics NASDAQ:PRCT

STAAR Surgical NASDAQ:STAA

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMCI, PRCT, BVS, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMCI, PRCT, BVS, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMCI, PRCT, BVS, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI, PRCT, BVS, and STAA Company Descriptions

Bioventus NASDAQ:BVS

PROCEPT BioRobotics NASDAQ:PRCT

STAAR Surgical NASDAQ:STAA

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools